Active: new fund Mar 2025 Verified 5 Nov 2026
Frazier Life Sciences
Palo Alto biotech investment firm with venture and public strategies that builds and backs companies developing novel therapeutics, with $6.9B+ under management.
- Type
- VC firm
- Location
- Palo Alto, California, United States
- Stages
- Pre-seed, Seed, Series A, Series B, Growth
- Backs
- Biotech and pharma
- Sectors
- Biotech, Healthtech and life sciences
- Fund size / AUM
- $6.97B gross private fund assets (Form ADV; private funds: 8, of which venture capital: 4)
- Latest fund or filing
- 17 Mar 2025
- Portfolio mix
- Biotech and pharma 100% (n=30, 2018 to 2026)
- Website
- www.frazierls.com
Contacts on file
For Frazier Life Sciences, the paid file holds: 6 named decision-makers with roles; LinkedIn page.
Get US Complete, $197 Free sample
One-time payment. No subscription. No account.
Notable investments
ArcutisKrystal BiotechAmunix Pharmaceuticals
Sources
- adviserinfo.sec.gov/firm/summary/317522
- frazierls.com/
- frazierls.com/portfolio/
- www.sec.gov/Archives/edgar/data/2052255/000205225525000001/
- adviserinfo.sec.gov/firm/summary/157324
- frazierls.com/team/
Last checked 5 Nov 2026. Is something wrong? Tell us.
Appears in 59 lists
Series B investors in Silicon Valley (29)Series B biotech investors in the US (34)Growth-stage investors in Silicon Valley (41)Growth-stage biotech investors in the US (44)Biotech investors in Silicon Valley (48)Series A biotech investors in the US (59)Series B investors in California (60)Series A investors in Silicon Valley (67)Series B healthtech investors in the US (69)Growth-stage investors in the San Francisco Bay Area (71)Series B biotech investors (73)Pre-seed investors in Silicon Valley (75)Pre-seed biotech investors in the US (81)Biotech investors in the San Francisco Bay Area (88)Growth-stage investors in California (89)Healthtech investors in Silicon Valley (91)Biotech investors in California (108)Growth-stage biotech investors (109)Series A investors in the San Francisco Bay Area (112)Growth-stage healthtech investors in the US (121)Series A investors in California (136)Pre-seed biotech investors (148)Seed investors in Silicon Valley (152)Series A biotech investors (153)Seed biotech investors in the US (159)Series B healthtech investors (160)Pre-seed investors in the San Francisco Bay Area (164)Series A healthtech investors in the US (164)Series B investors in the US (165)Healthtech investors in the San Francisco Bay Area (182)Pre-seed investors in California (207)Pre-seed healthtech investors in the US (225)Healthtech investors in California (240)Growth-stage investors in the US (288)Biotech venture capital firms in the US (297)Seed biotech investors (300)Growth-stage healthtech investors (316)Seed investors in the San Francisco Bay Area (324)Series B investors (339)Venture capital firms in Silicon Valley (341)Series A investors in the US (372)Series A healthtech investors (401)Pre-seed healthtech investors (408)Seed investors in California (415)Seed healthtech investors in the US (437)Biotech investors (484)Pre-seed investors in the US (549)Growth-stage investors (705)Healthtech venture capital firms in the US (709)Venture capital firms in the San Francisco Bay Area (768)Seed healthtech investors (800)Series A investors (864)Pre-seed investors (988)Venture capital firms in California (1,038)Seed investors in the US (1,043)Healthtech investors (1,207)Active venture capital firms in the US (1,574)Seed investors (1,892)Venture capital firms in the US (2,975)